five

Dataset from An Open-label Follow-up Trial of the Efficacy and Safety of Chronic Administration of the Fixed Dose Combination of Telmisartan 80 mg + Hydrochlorothiazide 25 mg Tablets Alone or in Combination With Other Antihypertensive Medications in Patients With Hypertension.

收藏
NIAID Data Ecosystem2026-05-02 收录
下载链接:
https://doi.org/10.25934/00003435
下载链接
链接失效反馈
官方服务:
资源简介:
The primary objective is to assess the efficacy and safety of the fixed dose combination of telmisartan 80 mg + hydrochlorothiazide 25 mg (T80/H25) alone or in addition to other antihypertensive therapies during open-label, long-term treatment.
创建时间:
2024-11-26
二维码
社区交流群
二维码
科研交流群
商业服务